|12th February 2021||Gregory D Wasson||682,500||Open or private purchase||$0.00|
|29th January 2021||Douglas P Baker||5,032||Open or private sale||$47.25||$237,762.00|
|29th January 2021||Douglas P Baker||4,315||Exercise of derivative||$7.51||$32,405.65|
|13th January 2021||Douglas P Baker||5,000||Exercise of derivative||$7.51||$37,550.00|
|13th January 2021||Douglas P Baker||5,000||Open or private sale||$38.89||$194,450.00|
|4th January 2021||Douglas P Baker||8,334||Open or private sale||$32.88||$274,021.92|
|4th January 2021||Douglas P Baker||4,000||Exercise of derivative||$7.51||$30,040.00|
|4th January 2021||Douglas P Baker||4,566||Exercise of derivative||$2.46||$11,232.36|
|31st December 2020||Ellen O'Connor Vos||802||Grant/award etc.||$0.00|
|31st December 2020||Gregory D Wasson||802||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 9/10.
OptimizeRx Corp. engages in the provision of digital health messaging via electronic health records. It offers EHR workflow solutions which include financial messaging, patient education, and brand messaging; and brand support. The company was founded by David A. Harrell on November 8, 1985.